Skip to Content
Merck
  • miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts.

miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts.

Nucleic acids research (2013-04-13)
Loredana Pellegrino, Justin Stebbing, Vania M Braga, Adam E Frampton, Jimmy Jacob, Lakjaya Buluwela, Long R Jiao, Manikandan Periyasamy, Chris D Madsen, Matthew P Caley, Silvia Ottaviani, Laura Roca-Alonso, Mona El-Bahrawy, R Charles Coombes, Jonathan Krell, Leandro Castellano
ABSTRACT

Uncontrolled cell proliferation and cytoskeletal remodeling are responsible for tumor development and ultimately metastasis. A number of studies have implicated microRNAs in the regulation of cancer cell invasion and migration. Here, we show that miR-23b regulates focal adhesion, cell spreading, cell-cell junctions and the formation of lamellipodia in breast cancer (BC), implicating a central role for it in cytoskeletal dynamics. Inhibition of miR-23b, using a specific sponge construct, leads to an increase of cell migration and metastatic spread in vivo, indicating it as a metastatic suppressor microRNA. Clinically, low miR-23b expression correlates with the development of metastases in BC patients. Mechanistically, miR-23b is able to directly inhibit a number of genes implicated in cytoskeletal remodeling in BC cells. Through intracellular signal transduction, growth factors activate the transcription factor AP-1, and we show that this in turn reduces miR-23b levels by direct binding to its promoter, releasing the pro-invasive genes from translational inhibition. In aggregate, miR-23b expression invokes a sophisticated interaction network that co-ordinates a wide range of cellular responses required to alter the cytoskeleton during cancer cell motility.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Vinculin antibody, Mouse monoclonal, clone hVIN-1, purified from hybridoma cell culture